Enzyme-linked immunosorbent assays (ELISA) for the detection of specific immunoglobulin G (IgG) and IgM antibodies were developed by using purified CoxieUla burnetii cells. Variables, including type of microtiter plate, blocking agent, incubation conditions, antigen stability, and substrate type, were examined to achieve optimal ELISA performance. The reliabilities of the assay systems were compared with those of complement fixation (CF) and enhanced immunofluorescence (ElF) tests with 600 human serum samples from defined clinical cases of Q fever, routine samples, and serum specimens from farmers. ELISA and EIF test results agreed in all cases. Dot immunoblotting was also used to test some of these sera and gave a rapid, qualitative result, which agreed with ELISA and EIF test results in all cases. No instances were found in which both ELISA and EIF test results were negative and the CF test result was positive. However, approximately 5% of the sera were positive by ELISA and the EIF test while the CF test result was either negative or unreadable because of serum anticomplementary activity. We conclude that dot immunoblotting is a useful screening test, whereas ELISA and the EIF test are both rapid and sensitive tests when used for the serodiagnosis of Q fever and should be considered to be replacements for the CF test.
Q fever is primarily a zoonosis, causing inapparent infection in domestic livestock worldwide (8) . Human infection is due mainly to aerosol transmission of the causative organism Coxiella bumetii from infected animals. Exposure may lead to inapparent infection; if overt disease develops, it usually is similar to an atypical pneumonia, with chills, malaise, and severe headache. In approximately 2% of cases (17) , the chronic form occurs. The chronic form may appear as endocarditis or hepatitis, requires long-term antibiotic therapy or surgery, and can be fatal (12) . Human Q fever is associated mainly with rural populations, veterinary or abattoir workers, and with travellers (22) and has an apparently low incidence rate, with approximately 150 cases per year in England and Wales being reported to the Communicable Disease Surveillance Centre (21) . This is likely to be an underestimation due in part to incorrect diagnosis, especially of the acute form, and also to unreliable laboratory serological methods.
Diagnosis of Q fever in humans can be made via isolation of the causative organism from clinical specimens by using animal inoculation or tissue culture (23) , but this is hazardous and demanding for most clinical laboratories. Traditionally the complement fixation (CF) test has been used to detect antibody response to this disease in the laboratory. Two distinct types of antibody are produced in a temporal manner; phase II antibodies appear early in infection, while phase I antibodies arise later and usually only to a relatively low level, except in the chronic form of the disease, in which they tend to become greatly elevated. However, in the majority of cases only a single convalescent-phase serum sample is available for testing and, as antibodies to C. burnetii can persist with titers decreasing at different rates, current Q fever may be difficult to diagnose. The CF test suffers from the tendency for sera from patients with Q fever to be anticomplementary. Also, the test is tedious and relatively slow, taking 2 days to complete, and usually relies on the accurate visual interpretation of erythrocyte hemolysis (2) . Other methods of laboratory serodiagnosis which have been described for Q fever include agglutination (11, 14) and immunofluorescence (1, 7, 13, 19) tests and the enzyme-linked immunosorbent assay (ELISA) (4, 15, 24, 27) . The last two methods are reported to detect types or classes of antibody different from those detected by the CF test (10) and are able to determine the presence of specific immunoglobulins in test sera. In Q fever, immunoglobulin G (IgG) levels increase early in infection and can persist for many years, while the presence of specific IgM may indicate active or recent infection (6, 10) . It has also been reported that the presence of specific humoral C. bumetii IgA in sera from patients with endocarditis is diagnostic (18) . Therefore, laboratory detection of specific anti-C. burnetii immunoglobulins may be useful as a means of distinguishing the different forms of Q fever.
We have developed ELISA and enhanced immunofluorescent test and dot immunoblotting techniques for the detection of specific Q fever antibodies and have compared these methods with the CF test by using 600 human serum samples from various sources.
MATERIALS AND METHODS
C. burnetii. A standard egg-adapted phase II strain of C. burnetii was obtained from the Public Health Laboratory Service Division of Microbiological Reagents and Quality Control laboratory and grown in eggs to provide the antigen used for ELISA, the enhanced immunofluorescence (EIF)incubated at 35°C for up to 12 days, and then harvested. These were homogenized in 5 ml of sterile saline for 1 min.
Formalin was added to a final concentration of 0.5%, and the suspension was incubated at 37°C for 5 days and then stored at 4°C until required. C. burnetii cells were then separated by a series of centrifugations. Briefly, the inactivated egg yolk sac suspension was centrifuged at 6,000 x g for 60 min. The deposit was resuspended to its original volume in phosphatebuffered saline (PBS) containing formalin at a 0.25% final concentration and homogenized for 2 min. These centrifugation and homogenization steps were repeated three times except that the suspension was finally centrifuged at 550 x g for 10 min. The supernatant fluid from this was removed and centrifuged at 6,000 x g for 60 min. The deposit was then resuspended in PBS, and 10-ml volumes were carefully layered onto 25 [Schering Chemical Co.] in sterile distilled water) and centrifuged at 6,000 x g for 60 min. The deposits were washed four times by resuspending in PBS and further centrifuging at 6,000 x g for 60 min. The deposit was resuspended to a final concentration of 5% of the original yolk sac suspension. The final preparation was examined for purity by electron microscopy.
Human sera. Human sera were kindly made available by N. Lightfoot, Public Health Laboratory, Newcastle, United Kingdom, T. Coleman, Public Health Laboratory, Hereford, United Kingdom, and P. Morgan-Capner, Public Health Laboratory, Preston, United Kingdom. A total of 430 serum samples were collected from farmers in Hereford and Somerset. Thirty-eight serum samples were from patients having clinically defined Q fever confirmed by the demonstration of an increasing C. burnetii phase II antibody titer by the CF test; 132 serum samples were selected from specimens sent to the Centre for Applied Microbiology and Research for Rickettsia and Coxiella testing, 44 of which were positive for various Rickettsia antibodies. Normal sera used as negative controls in ELISA, the EIF and CF tests, and DIB tests were from individuals with no clinical history suggestive of Q fever.
Complement fixation. The CF test for antibodies specific for phase I and phase II C. burnetii antigens was the standard Public Health Laboratory Service method, using antigens and control sera (available from Public Health Laboratory Service DMRQC, Colindale). Serial doubling dilutions of sera were allowed to react overnight with phase I and phase II antigens together with guinea pig complement (Behring). Complement not fixed by antigen-antibody complexes was detected by the lysis of antibody-sensitized sheep erythrocytes. The end-point titer was taken at the dilution which showed 50% hemolysis relative to the control titration of the complement. A positive CF result was indicated by a titer of 1/10 or higher.
Immunofluorescence. The EIF test was based on the standard fluorescent antibody methods (5, 18, 20) with the addition of biotinylated antibody conjugate (Vector Laboratories) and avidin-biotin labelled with a fluorochrome (Vector Laboratories) to enhance the fluorescence signal. In brief, purified whole-cell C. burnetii antigen was diluted to give approximately 103 to 104 fluorescing organisms per microscopic field (100 x oil immersion objective) and spotted onto 15-well microscope slides (Flow Laboratories). After being air dried, the slides were fixed with ice-cold acetone for 10 min and stored with desiccant at -20°C until required.
Serial doubling dilutions of sera to be tested, ranging from 1/40 to 1/2,560, were prepared in PBS, pH 7.2. Ten microliters of each dilution was spotted onto the slide wells and allowed to react at room temperature in a humid chamber for 30 min. After three washes in PBS, 0.01 ml of biotinylated goat anti-human IgG or IgM was added to each well and the slides were incubated for 30 min at room temperature. After being washed for 30 min in PBS, 0.01 ml of avidin-biotin fluoroisothiocyanate conjugate (Nordic Immunology) was spotted onto the slide wells and incubated as described previously. Following three washes in PBS and one in distilled water, slides were mounted in PBS-glycerol (Citifluor Ltd.) and examined at a magnification of x 1,000 by using a Nikon Diaphot-TMD microscope with a UV source. The antibody titer was evaluated qualitatively by reference to positive and negative controls on the same slide and was defined as the inverse of the highest dilution showing unequivocal fluorescent staining of the Coxiella cell membrane. A positive EIF result was indicated by a titer of 1/100 or higher.
ELISA. An indirect ELISA method (9) was used. The optimal concentration of antigen was determined to be 4 jig per well by chessboard titration and also by reference to an estimation of the total protein (bicinchoninic acid; Pierce). The wells of flat-bottomed, sterile 96-well microtiter plates (ProBind; Falcon) were coated with 0.1 ml of antigen suspension at the optimal concentration in coating buffer (0.04 M sodium carbonate, 0.06 M sodium bicarbonate in sterile distilled water, pH 9.6). The optimal time and temperature of incubation during coating of the plates were found to be 4°C for at least 8 h. For convenience, plates were usually left overnight. Microtiter plates, coated with antigen, were either used immediately or else thoroughly air dried and then sealed in plastic film and stored at 4°C until required. The presence of specific IgM was assayed as described above, with the exception that each serum sample was pretreated with goat anti-human IgG antibody (MastSorb; Mast Laboratories) as directed by the manufacturer to remove any possible interference from rheumatoid factor (25, 26 The total protein content of the cell suspension was estimated to be between 35 and 40 mg/ml. The optimum antigen coating concentration for ELISA of 0.004 mg per well was determined by chessboard titration. The optimum concentration of antihuman antibody conjugated to HRP for ELISA were determined to be 1/4,000 for both IgG and IgM. The so-called "edge effect" in ELISA microtiter plate tests, in which differences may occur in binding of the sample to the outer wells (16) probably because of a thermal gradient across the plate, was not apparent in our ELISA. Plates were incubated singly without lids on small shelves in a fan-assisted incubator to improve circulation of air. Also, the ELISA antigen-coated plates were stable, showing no loss of antibody binding capability over an 8-month period. The substrate tetramethylbenzidine was found to give a higher positive/negative OD ratio than that obtained with o-phenylenediamine, with a lower background OD, and tetramethylbenzidine is also reported to be nonmutagenic (3 The major conclusion from this work is that the immunofluorescence and enzyme-linked assays are equally effective in determining the presence of specific anti-C. bumnetii antibodies, and both are superior to the CF test. We therefore suggest that the fluorescent technique be adopted as a rapid and reliable means of screening relatively small numbers of sera. This should be especially easy for laboratories already using indirect immunofluorescence for measuring levels of antibody to other infectious agents such as legionellae and Treponema pallidum.
ELISA for the detection of specific IgG and IgM using phase II antigen has also been shown to be a sensitive, rapid, and reliable means of screening large numbers of sera for epidemiological studies or as a reference method for the early and rapid detection of Q fever.
